
| Salt Composition: | Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg) |
| Manufacturer: | Fortune Life Sciences Private Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Kandoxime CV 50mg/31.25mg Dry Syrup is a potent antibiotic used to treat severe bacterial infections in children, targeting the ear, throat, lungs, skin, and urinary tract. Kandoxime CV 50mg/31.25mg Dry Syrup is a combination of two active medicines, Cefpodoxime Proxetil and Clavulanic Acid. It works by inhibiting the growth of bacteria, thereby preventing the infection spread. It is given to children to treat a wide range of severe bacterial infections.
Kandoxime CV 50mg/31.25mg Dry Syrup is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic that works by preventing the formation of the bacterial protective covering, which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
Kandoxime CV 50mg/31.25mg Dry Syrup should only be given to children as prescribed by a doctor. It should not be shared with anyone else, even if they show similar symptoms.